Dr. Schwarz is a 1964 graduate of Tulane University School of Medicine. Following that, he completed his internship, residency, and fellowship at Tulane University and Charity Hospital in New Orleans, Louisiana. He is a diplomate of the Board of Internal Medicine as well as the Pulmonary Disease subspecialty Board. He is currently the James C. Campbell Professor of Medicine. He served as Division Head of the Pulmonary Sciences and Critical Care Medicine division from 1983-2005 at the University of Colorado, Denver. He has received multiple honors including the Trudeau Medal from the American Thoracic Society and was elected to the Association of American Physicians. In addition to multiple other honors he is nationally and internationally known for his investigations of pulmonary fibrosis. He currently is the head of the steering committee of the NHLBI IPF Network. He has published over 150 peer-reviewed papers in addition to 200 editorials, chapters, books, and invited papers. His primary interests currently are in the genetic and environmental factors which influence the development of pulmonary fibrosis, particularly idiopathic pulmonary fibrosis. He serves in an advisory capacity to several pharmaceutical companies interested in the development of agents for the treatment of IPF. Zisman DA, Schwarz, MI, Anstrom KJ, Collard HR, Flaherty KR, Hunninghake GW. For the Idiopathic Pulmonary Fibrosis Treatment Network Investigators, Member of the Protocol and Writing Committees . A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis. N Engl J Med 2010; 363: 620-628.
Biography Updated on 16 April 2013